Design Therapeutics Inc. (DSGN)

DSGN trades at $6.08, 21.6% above the near-term max pain of $5 expiring Oct 17, 2025 (14 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($1-$5), signaling increased put positioning or downside protection. Key magnetic zone at 5 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for DSGN shows a downward trend from 5 to 1, indicating bearish sentiment or hedging activity. The 119% spread signals divergent expectations across timeframes. Most levels below 6.08 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.